MedPath

PathMaker Neurosystems Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study

Not Applicable
Recruiting
Conditions
ALS - Amyotrophic Lateral Sclerosis
First Posted Date
2024-10-21
Last Posted Date
2025-05-31
Lead Sponsor
PathMaker Neurosystems Inc.
Target Recruit Count
15
Registration Number
NCT06649955
Locations
🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Early Feasibility Study of the MyoRegulator® for Treatment of ALS

Not Applicable
Completed
Conditions
Amyotrophic Lateral Sclerosis
First Posted Date
2023-12-11
Last Posted Date
2025-03-25
Lead Sponsor
PathMaker Neurosystems Inc.
Target Recruit Count
5
Registration Number
NCT06165172
Locations
🇺🇸

Spaulding Rehabilitation Hospital, Charlestown, Massachusetts, United States

Study Evaluating MyoRegulator® Treatment in Post-Stroke Upper Limb Spasticity

Not Applicable
Terminated
Conditions
Stroke
Muscle Spasticity
First Posted Date
2021-02-08
Last Posted Date
2024-08-15
Lead Sponsor
PathMaker Neurosystems Inc.
Target Recruit Count
28
Registration Number
NCT04742257
Locations
🇺🇸

Spaulding Rehabilitation Hospital, Charlestown, Massachusetts, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.